RNA5SP290

Across TCGA pan-cancer cohorts, RNA5SP290 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RNA5SP290 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher RNA5SP290 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP290 expression acts as an unfavorable survival marker, although some lineages such as KIRC and CESC show a favorable association.

CHOL, KIRC, and OV are the cancer types where RNA5SP290 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	III,IV	0.162	0.915	.004	54	view →
KIRC	DFS	Median	All	0.753	0.500	<.001	40	view →
OV	OS	Tertile	II,III,IV	0.236	0.344	.011	36	view →
CESC	OS	Tertile	II,III,IV	0.958	0.706	.010	36	view →
ACC	OS	Tertile	All	0.113	0.822	<.001	36	view →
THCA	DFS	Quartile	II,III,IV	0.725	0.890	.005	31	view →
MESO	OS	Tertile	IV	0.230	0.680	.005	27	view →
KICH	DFS	Median	II,III,IV	1.000	0.601	.008	22	view →
DLBC	DFS	Tertile	All	0.435	0.906	.009	18	view →
LIHC	OS	Tertile	II,III,IV	1.000	0.399	.033	18	view →
LGG	OS	Median	All	0.367	0.497	.002	17	view →
UVM	OS	Tertile	III,IV	0.288	0.674	.016	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

RNA5SP290–CHOL (OS)

Open the CHOL breakdown →